Niihara Yutaka

Chairman and CEO, Director, 10% OwnerEmmaus Life Sciences, Inc. (EMMA) · full profile →Form 4 · filed Oct 12, 2022
Net Buying
Open-Market Buys
$20K
Open-Market Sells
$0
Net Open-Market Flow
$20K
Transactions
9
9 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 11, 2022Buy(P)130K$0.09$12K11.5M
Oct 10, 2022Buy(P)10K$0.09$90011.4M
Oct 7, 2022Buy(P)4K$0.13$52011.4M
Oct 6, 2022Buy(P)5K$0.15$75011.4M
Oct 5, 2022Buy(P)10K$0.15$2K11.4M
Oct 4, 2022Buy(P)5K$0.16$80011.4M
Oct 3, 2022Buy(P)10K$0.20$2K11.4M
Sep 27, 2022Buy(P)5K$0.20$1K11.3M
Sep 26, 2022Buy(P)6K$0.20$1K11.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-053433) within minutes of acceptance. Every field above traces to the original document. Verify it directly: